HealthAbbott Reports 72.2% WGS Sensitivity for Two-Year Colorectal RecurrenceBy Naomi CalderOct 23, 2026, 11:58 PM UTC
BusinessAbbott Keeps 2026 Earnings Midpoint as Q3 Sales Top EstimateBy Helena WardOct 22, 2026, 6:57 AM UTC
HealthAbbott Says Cologuard Plus Received CE Mark for Colorectal ScreeningBy Naomi CalderOct 21, 2026, 12:48 AM UTC